Perrigo Absorbs Plant Remediation Sales Hit, But PBM Progresses In Q1
This article was originally published in The Tan Sheet
Executive Summary
Continuing remediation at a facility that received an FDA warning letter took a bite out of first-quarter sales for Perrigo, but the private labeler sees continued upside in branded competitor recalls and infant formula growth in the rest of fiscal 2011.
You may also be interested in...
FDA Enforcement In Brief
Perrigo facility undergoes reinspection
FDA Enforcement In Brief
Perrigo facility undergoes reinspection
FDA Enforcement In Brief
Perrigo facility undergoes reinspection